Sulfonic acids, petroleum, magnesium salts

Genetic toxicity: in vivo

Administrative data

Endpoint:

in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus

Remarks:

Type of genotoxicity: DNA damage and/or repair

Type of information:

experimental study

Adequacy of study:

key study

Study period:

1989

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

other: Study conducted to OECD guidelines and to GLP, and therefore meets the criteria for Klimisch code 1.

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

1989

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)

GLP compliance:

yes

Type of assay:

micronucleus assay

Test material

Test material information

Constituent 1

Reference substance name:

Benzenesulfonic acid, mono-C16-24-alkyl derivs., calcium salts

EC Number:

274-263-7

EC Name:

Benzenesulfonic acid, mono-C16-24-alkyl derivs., calcium salts

Cas Number:

70024-69-0

IUPAC Name:

sodium 4-icosylbenzenesulfonate

Constituent 2

Reference substance name:

C20-24 alkaryl calcium salt derivative

IUPAC Name:

C20-24 alkaryl calcium salt derivative

Test material form:

not specified

Details on test material:

the test material was an analog of CAS 70024-69-0 described as C20-24 alkaryl calcium salt derivative

Test animals

Species:

mouse

Strain:

CD-1

Sex:

male/female

Details on test animals or test system and environmental conditions:

Male and female swiss albino Crl: CD-1 (ICR) BR aged 50 days at initiation.

Administration / exposure

Route of administration:

intraperitoneal

Vehicle:

- Vehicle(s)/solvent(s) used: peanut oil

Details on exposure:

single dose via intraperitoneal injection followed by a 72 hr evaluation period

Duration of treatment / exposure:

72 hours

Frequency of treatment:

Once

Doses / concentrations

Remarks:

Doses / Concentrations:
0, 100, 200, 400 and 500 mg/kg
Basis:
nominal conc.

No. of animals per sex per dose:

5

Control animals:

yes

Positive control(s):

triethylenemelamine positive control: 0.25 mg/kg, 5/sex; 100 and 500 mg/kg: 15/sex; 200 and 400 mg/kg: 18/sex; 500 mg/kg

Examinations

Tissues and cell types examined:

erythrocytes evaluated for micronuclei and ratio of non chromatic and polychromatic determined.

Evaluation criteria:

NCE/PCE ratio and % PCE versus total erythrocytes

Statistics:

Animal to animal variability in spontaneous frequency of micronucleated polychromatic eryocytes were evaluated in vehicle controls. Statistically significant differences were evaluated in the frequency of micronucleated polychromatic erythrocytes between treated groups and vehicle controls.
NCE/PEC (normochromatic eryhrocytes/polychromatic eryhrocytes) ratios in treated and control groups were compared. Tests included dispersion test of AmpWett and Delow, and Margolin, Fishers exact test, binomial approximation, Cochran-Artage test for trend, a one-way analysis of variance and Dunett's procedure.

Results and discussion

Test results

Sex:

male/female

Genotoxicity:

negative

Toxicity:

yes

Vehicle controls validity:

valid

Negative controls validity:

valid

Positive controls validity:

valid

Any other information on results incl. tables

During the main study, toxicity was observed at 400 and 500 mg/kg. at 500 mg/kg, 5 males and 4 females of 15/sex died prior to the scheduled sampling time. At 400 mg/kg, 1 of 18 treated females died on Day 3. Other clinical signs of toxicity included palpebral closure, decreased motor activity and weakness. Cytotoxicity was observed in both sexes. A statistically significant increase in NCE/PCE ratio was observed in individual animals of both sexes in other groups. Altered proportions of erythrocytes to nucleated cells were noted for both sexes in the treated group. No biological or statistical significant increase in the number of micronucleated PCE/100 PCE expected for control animals. The variability in response observed in the vehicle controls. The positive control exhibited a statistically significant increase in micronuclei as expected. Chemical analysis confirmed that the dosing solution preparation procedure utilized for this study resulted in homogeneous solutions of appropriate concentration.

Applicant's summary and conclusion

Conclusions:

Interpretation of results (migrated information): negative
Under the conditions of this study the test substance was not genotoxic.

Executive summary:

In a mouse bone marrow micronucleus assay, animals were treated via the peritoneum with C20-24 alkary calcium salt derivatives at doses of 0, 100, 200, 400 and 500 mg/kg bw. Bone marrow cells were harvested at 24, 48 and 72 hours post-treatment. The vehicle was peanut oil.

 

There were signs of toxicity during the study at 400 and 500 mg/kg. The positive control included the appropriate response. There was not a significant increase in the frequency of micronucleated polychromatic erythrocytes in bone marrow after any treatment time.

 

This study is classified as acceptable. This study satisfies the requirement for Test Guideline OECD 474 for in vivo cytogenetic mutagenicity data.